Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada...
and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 19, 2024 4:13pm
@ the Bell: Markets deeply divided amid Middle East flareup
Canada’s main stock index jumped on Friday, aiming to recoup some weekly losses, as investors shed caution around Middle East tensions.
read article.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Apr 18, 2024 5:52pm
GUD Motley fool article April 16, GUD shares +40%
https://www.fool.ca/2024/04/16/tsx-healthcare-in-april-2024-the-best-stocks-to-buy-right-now/ ***** Positioned for future success Knight Therapeutics trades slightly higher than WELL ($5
...more
Addition Of New Copper Claims at Topley Project
posted Apr 19, 2024 9:00am by
Geologica Resource Corp.
-
|
Geologica’s Topley Property is located in British Columbia, a global leader in the development of socially and environmentally responsible resources. Combined with a positive market sentiment for commodities like gold, silver, copper and molybdenum, Topley and Geologica are well-positioned to create significant value for shareholders ...read more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 18, 2024 4:17pm
@ the Bell: TSX keeps it just above the flatline
Driven by materials stocks tracking higher metals prices, utilities led gainers on the TSX while energy and industrials led the drop.
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 18, 2024 5:00am
Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions
Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.
read article.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Apr 16, 2024 12:46pm
GUD summary
Celebrating 10 years just past $343M revenues, cash flow & other(EBITDA) all record Exelon expense now normalize fr EBITDA to cash flow Cash Allows more
...more
(0)
•••
NSMTL05
X
View Profile
View Bullboard History
Comment by
NSMTL05
on Apr 11, 2024 1:13pm
RE:RE:Antibe
Thank you, wonder if they still have it
(0)
•••
NSMTL05
X
View Profile
View Bullboard History
Comment by
NSMTL05
on Apr 11, 2024 1:12pm
RE:RE:Antibe
Thank you, this is was also the only infor I was able to find
(14)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Apr 11, 2024 9:35am
RE:RE:Antibe
Yes, that's the last I've seen about it as well. CapIQ doesn't show Knight as one of the shareholders but they may have it wrong. Amal owns about 90k shares, apparently.
(21)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Apr 11, 2024 8:54am
RE:Antibe
They had a loan of $500,000 that was converted into shares. From the annual information form... "On March 27, 2018, Knight converted the debt into 2,489,889 Common Shares."
(0)
•••
NSMTL05
X
View Profile
View Bullboard History
Post by
NSMTL05
on Apr 10, 2024 8:49pm
Antibe
Anyone know if GUD had investments with Antibe, debt or equity? Thanks
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 09, 2024 7:30am
New Press Release - Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton &...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 28, 2024 11:04am
New Press Release - Knight Therapeutics Inc. ranks on The Globe and Mail's fifth-annual Women Lead Here benchmark of executive gender diversity
MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on Business magazine’s fifth annual Women Lead Here list. This annual editorial benchmark identifies top...
read article.
(42)
•••
luscar99
X
View Profile
View Bullboard History
Comment by
luscar99
on Mar 27, 2024 11:48am
RE:Again? Is it support or faith?
Trading the $5.25 - $5.75 channel.
(8)
•••
wofats
X
View Profile
View Bullboard History
Post by
wofats
on Mar 25, 2024 11:47pm
Again? Is it support or faith?
Increasing position Filed 2024-03-25 13:55 Tx date 2024-03-25 $GUD Knight Therapeutics Inc. Armoyan, Sime
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Mar 25, 2024 11:54am
418k+ shares traded!
!
(185)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Mar 21, 2024 5:58pm
RE:RE:RE:RE:New Press Release - Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results
Q4 was gross and the 2024 Guidance was underwhelming. The impairment bothers me a bit but I also understand that currency issue. I haven't listened to the conference call recording but will this
...more
(42)
•••
luscar99
X
View Profile
View Bullboard History
Comment by
luscar99
on Mar 21, 2024 11:47am
RE:RE:RE:New Press Release - Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results
Yes. Q4 was ugly. That's why idiots refer to the annual results.
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Mar 21, 2024 11:36am
RE:RE:New Press Release - Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results
You said everything is bad This? Revenues were $328,199, an increase of $34,636 or 12% over prior year. Revenues excluding IAS 29 were $343,138, an increase of $51,368 or 18% over
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors
The Increasing Investments by the Defense and Military Sectors is Driving the Demand for Helium
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%